A 63-year old man presented with massive splenomegaly, lymphadenopathy and a total leucocyte count of 17000 per mm3. The flow cytometery showed CD 23 negative and C 5 positive monoclonal cells with bright kappa positively comprising 80% of the peripheral blood lymphoid cells. The most likely diagnosis is –
**Core Concept**
The case presents with a combination of splenomegaly, lymphadenopathy, and a high total leucocyte count, along with specific flow cytometry findings indicating a clonal lymphoid proliferation. The flow cytometry results show CD23 negative and CD5 positive monoclonal cells with bright kappa positivity, suggesting a specific subtype of lymphoma.
**Why the Correct Answer is Right**
The clinical presentation and flow cytometry results are highly suggestive of a B-cell lymphoma, specifically a mantle cell lymphoma (MCL). MCL is characterized by the presence of CD5 positive, CD23 negative B cells, which express bright kappa light chain restriction. This pattern is due to the monoclonal proliferation of neoplastic B cells, which express the CD5 antigen and lack the CD23 antigen. The high percentage of kappa-positive cells (80%) further supports the diagnosis of a B-cell lymphoma.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because CLL (Chronic Lymphocytic Leukemia) typically presents with CD23 positive, CD5 positive cells, and the cells often co-express CD20. The absence of CD23 and presence of bright kappa positivity in this case makes CLL less likely.
* **Option B:** This option is incorrect because Follicular Lymphoma typically presents with CD10 positive, CD5 negative cells, and the cells often co-express BCL2. The presence of CD5 positivity in this case makes Follicular Lymphoma less likely.
* **Option C:** This option is incorrect because Diffuse Large B-Cell Lymphoma (DLBCL) typically presents with CD10 positive, CD5 negative cells, and the cells often co-express BCL2. The presence of CD5 positivity and bright kappa positivity in this case makes DLBCL less likely.
**Clinical Pearl / High-Yield Fact**
Mantle cell lymphoma often presents with a more aggressive clinical course and may require more intensive treatment approaches, including chemotherapy and targeted therapies. The presence of CD5 positivity and CD23 negativity in a B-cell lymphoma should raise suspicion for MCL.
**Correct Answer: D. Mantle Cell Lymphoma**